Axis Capital Holdings Ltd. (AXS)
NYSE NYSE Primary 
XFRA 
Why Is Axis Capital (AXS) Up 5% Since Last Earnings Report?
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
Why Axis Capital (AXS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AXIS Capital Holdings Limited (AXS) Q2 2025 Earnings Call Transcript
AXIS Capital Holdings Limited (NYSE:AXS ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Clifford Henry Gallant - Head of Investor Relations & Corporate Development Peter John Vogt - Interim Principal Accounting Officer, CFO & Executive VP Vincent Christopher Tizzio - President, CEO & Director Conference Call Participants Andrew E. Andersen - Jefferies LLC, Research Division Andrew Scott Kligerman - TD Cowen, Research Division Brian Robert Meredith - UBS Investment Bank, Research Division Charles William Lederer - BMO Capital Markets Equity Research Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Joshua David Shanker - BofA Securities, Research Division Meyer Shields - Keefe, Bruyette, & Woods, Inc., Research Division Operator Good day, and welcome to the AXIS Capital Second Quarter 2025 Earnings Conference Call.
AXIS Capital Q2 Earnings Surpass Estimates, Premiums Increase Y/Y
AXS' Q2 results reflect improved underwriting income across both segments, higher net premiums earned, offset by higher expenses.
Axis Capital (AXS) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Axis Capital (AXS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Axis Capital (AXS) Q2 Earnings Surpass Estimates
Axis Capital (AXS) came out with quarterly earnings of $3.29 per share, beating the Zacks Consensus Estimate of $2.88 per share. This compares to earnings of $2.93 per share a year ago.
Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy
Axsome's valuation is driven by its promising pipeline, with Auvelity as a proven commercial success and Symbravo and AXS-12 showing solid potential. Recent setbacks include the FDA's refusal to file AXS-14 and Sunosi's failure in MDD studies, but ADHD data for Sunosi is encouraging. I estimate $3bn in peak revenues by the mid-2030s, which supports a Buy rating despite management's more ambitious projections.
Earnings Preview: Axis Capital (AXS) Q2 Earnings Expected to Decline
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Axis Capital (AXS) is Poised to Beat Earnings Estimates Again
Axis Capital (AXS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AXS Outperforms Industry, Trades at a Discount: How to Play the Stock
AXIS Capital gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.
Why Is Axis Capital (AXS) Up 5.3% Since Last Earnings Report?
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock?
AXS vs. ACGL: Which P&C Insurance Stock Should You Hold Now?
Let's see how AXS and ACGL fare in terms of some of the key metrics.
